Inogen Q1 2023 Earnings Report $9.91 -0.37 (-3.60%) As of 02/21/2025 04:00 PM Eastern Earnings HistoryForecast Inogen EPS ResultsActual EPS-$0.63Consensus EPS -$0.77Beat/MissBeat by +$0.14One Year Ago EPS-$0.38Inogen Revenue ResultsActual Revenue$72.16 millionExpected Revenue$74.68 millionBeat/MissMissed by -$2.52 millionYoY Revenue Growth-10.20%Inogen Announcement DetailsQuarterQ1 2023Date5/4/2023TimeAfter Market ClosesINGN Upcoming EarningsInogen will be holding an earnings conference call on Tuesday, February 25 at 5:00 PM Eastern. Interested parties can register for or listen to the call or dial in at 201-612-7415 using passcode "13750589". Conference Call ResourcesConference CallConference Call TranscriptSlide DeckPress ReleaseINGN Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Slide DeckFull Screen Slide DeckPowered by Inogen Earnings HeadlinesStockNews.com Upgrades Inogen (NASDAQ:INGN) to "Buy"February 12, 2025 | americanbankingnews.comAntea Group: Keith Knoke Appointed Chair of the Board of Directors for Inogen AllianceFebruary 11, 2025 | finanznachrichten.deCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?February 22, 2025 | Investors Alley (Ad)Inogen Alliance: Webinar: Understanding PFAS - Risks, Regulations, and Remedies - A Global PerspectiveFebruary 11, 2025 | finanznachrichten.deInogen Board Reshuffle with Sahney AppointmentFebruary 3, 2025 | tipranks.comInvestors in Inogen (NASDAQ:INGN) have unfortunately lost 75% over the last five yearsJanuary 31, 2025 | uk.finance.yahoo.comSee More Inogen Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Inogen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inogen and other key companies, straight to your email. Email Address About InogenInogen (NASDAQ:INGN), a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.View Inogen ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles The Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity? Upcoming Earnings Workday (2/24/2025)Intuit (2/25/2025)American Tower (2/25/2025)Bank of Montreal (2/25/2025)Bank of Nova Scotia (2/25/2025)Public Storage (2/25/2025)NVIDIA (2/26/2025)Synopsys (2/26/2025)Salesforce (2/26/2025)Lowe's Companies (2/26/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
